NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Neumora Therapeutics, Inc. (“Neumora” or “the Company”) (NASDAQ:NMRA) and certain of its officers.
Class Definition
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Neumora securities pursuant to the registration statement and prospectus issued in connection with the Company’s September 15, 2023 initial public offering (“IPO”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/NMRA.
Case Details
The Complaint alleges that, unbeknownst to investors, Neumora’s Phase Three Program, including the KOASTAL-1 study, was riddled with risks and uncertainties that were well known by the Company at the time of the IPO. Specifically, the Complaint alleges that the Offering …
